These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23851053)

  • 1. Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40.
    Windisch M; Flunkert S; Havas D; Hutter-Paier B
    Ageing Res Rev; 2013 Sep; 12(4):852-4. PubMed ID: 23851053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
    Li C; Ebrahimi A; Schluesener H
    Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease.
    Smith JD; Chakrabarti E; Levin-Allerhand JA
    J Mol Neurosci; 2004; 24(1):145-7. PubMed ID: 15314263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Models of Alzheimer's Disease.
    Esquerda-Canals G; Montoliu-Gaya L; Güell-Bosch J; Villegas S
    J Alzheimers Dis; 2017; 57(4):1171-1183. PubMed ID: 28304309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
    Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
    Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
    García-Barroso C; Ricobaraza A; Pascual-Lucas M; Unceta N; Rico AJ; Goicolea MA; Sallés J; Lanciego JL; Oyarzabal J; Franco R; Cuadrado-Tejedor M; García-Osta A
    Neuropharmacology; 2013 Jan; 64():114-23. PubMed ID: 22776546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.
    Bales KR
    Expert Opin Drug Discov; 2012 Apr; 7(4):281-97. PubMed ID: 22458501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical considerations for choosing a mouse model of Alzheimer's disease.
    Jankowsky JL; Zheng H
    Mol Neurodegener; 2017 Dec; 12(1):89. PubMed ID: 29273078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
    Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
    Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of aricept with a traditional Chinese medicine formula, smart soup, may be a novel way to treat Alzheimer's disease.
    Wang Y; Wang Y; Sui Y; Yu H; Shen X; Chen S; Pei G; Zhao J; Ding J
    J Alzheimers Dis; 2015; 45(4):1185-95. PubMed ID: 25690664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APP transgenic mice and their application to drug discovery.
    Howlett DR
    Histol Histopathol; 2011 Dec; 26(12):1611-32. PubMed ID: 21972099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.